Abstract:Objective To construct the replication-deficient recombinant adenovirus carrying vasostatin gene and study its inhibitory effect on pancreatic cancer. Methods A cDNA clone encoding vasostatin was isolated from human skeletal muscle cDNA library by polymerase chain reaction. The shuttle plasmid, pshuttle-CMV-vasostatin, in which the amplified fragment was inserted into the downstream of the cytomegalovirus promoter, was established by ligation. After identification by digestion and sequencing, linearize the shuttle plasmid with Pme I, and then transform the linearized shuttle plasmid into E.coli BJ5183-AdEasy-1 by electroporation. The plasmid was named as pAd-CMV-vasostatin after homologous recombination and identification by kanamycin-selection and restriction digestion. The recombinant plasmid was transfected into cell 293. The recombinant adenovirus was detected by examining the presence of cytopathic effect and identified by polymerase chain reaction. Both RT-PCR and western blotting were used to identify the expression of vasostatin. The xenografted nude mice with pancreatic cancer were established to observe the inhibitory effect of vasostatin on tumor growth. The volume of xenografts was measured every three days during the 3-week treatment. The weight of xenografts was measured at the end of the 21st day. Results The PCR product was about 560 bp confirmed by agarose gel electrophoresis. The successful cloning of vasostatin into pshuttle-CMV was confirmed by restriction endonuclease analysis, and the gene of interest was identified as vasostatin by nucleotides sequencing technique. The recombinants were selected for kanamycin resistance and the recombination was confirmed by the presence of 4.5kb fragment in the restriction endonuclease analysis. The cytopathic effect present after 7 days in cell 293 transfected with linearized pAd-CMV-vasostatin. Both the cytopathic effect of cell 293 and the 560 bp PCR producet indicated the presence of the recombinant adenovirus containing vasostatin gene. The expression of vasostatin was identified by RT-PCR and western blotting. The volume and weight of xenografts in pAd-CMV-vasostatin group were significantly smaller than those in pAd-CMV-LacZ group and PBS group. Conclusion The recombinant adenovirus containing vasostatin gene was constructed successfully, and could significantly inhibit the growth of xenografted pancreatic cancer in nude mice.

Construction of a recombinant adenovirus vector carrying human canstatin gene and adenovirus preparation

[Construction of a Recombinant Adenoviral Vector Expressing Human Endostatin].

[Construction and Expression of Recombinant Adenovirus Vector Carrying Human Endostatin, K5 and Endostatin-K5 Gene].

Cloning and Expression of Human Canstatin and Identification of Its Biological Activity

Construction of human STAT3 recombinant adenovirus vector and its effect on gastric cancer cell line SGC-7901

[Construction of Recombinant Adenovirus Vector of Calcitonin Gene-Related Peptide Gene and Transfection to Neonatal Rat Cardiomyocytes].

[Construction and expression of recombinant adenovirus containing human catalase gene in vitro].

Construction and identification of green fluorescent protein labeled recombinant adenovirus containing human vascular endothelial growth factor 165 gene

Construction of Replication-Deficient Recombinant Adenovirus Carrying Vasostatin Gene and Its Inhibitory Effect on Pancreatic Cancer

Cloning of connective tissue growth factor gene and construction of recombinant adenovirus vector Ad5-CTGF

Study on the Construction of Recombinant AAV Vector Mediated Tumstatin Gene and Its Activity

Construction of Recombinant Adenovirus for the Angiogenic Inhibitor,Vasostatin,and Its Expression in Vitro

[Study on Construction of Chimeric Adenovirus Vector Ad5/11 Carrying Human Egfp and Endostatin-K5 and Its Experimental Investigation in Vitro].

Construction and target gene expression of adenovirus vectors containing angiogenin-1/vascular endothelial growth factor 165

[Construction of Recombinant Adenovirus Vector of Mouse Keratinocyte Growth Factor].

Construction and Target Gene Expression of Recombinant Adenovirus Vectors Containing Vascular Endothelial Growth Factor 165 and Angiopoietin-1

Construction and Application of Recombinant Adenovirus Vector Expressing the Mouse Endostatin

Construction and Expression of Bicistronic Adenovirus Vector Carrying Thymidine Kinase and Enhanced Green Fluorescent Protein Gene.

Construction of Recombinant Adenovirus Vector Containing Human ggpps Gene and Its Effect on Activation of HSCs

Construction of recombinant adenovirus vector carrying CysC gene and its expression in rat cardiac fibroblast

Construction of Recombinant Adenovirus Vector Expressing Murine Endostatin Gene and Its Effect on Human Lung Adenocarcinoma Cell Line SPCA-1